Exports growth offset by weak India business

Company
30 May 2024
5 Min read 
  • Alkem Laboratories 4QFY24 results update
  •  Exports growth offset by weak India business
  •  Increasing investments in the biosimilars segment
  •  Miss on 4QFY24 earnings due to lower domestic formulation sales
  •  Earnings growth in FY24 due to lower raw material cost
  •  Reduction in earnings estimate for FY25/FY26
  •  Neutral stance on the stock due to limited upside
Login / Open Demat Account to read the report

Never Miss Out on Hot Market Updates

Get exclusive market news delivered to your inbox - on priority